Sangani Hospitals Ltd
Incorporated in 2021, Sangani Hospitals is in the business of Hospital, Laboratory, and Pharmacy[1]
- Market Cap ₹ 80.5 Cr.
- Current Price ₹ 58.4
- High / Low ₹ 78.0 / 48.5
- Stock P/E 42.6
- Book Value ₹ 26.9
- Dividend Yield 0.00 %
- ROCE 9.91 %
- ROE 7.44 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 9.54% over last 3 years.
- Earnings include an other income of Rs.1.07 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| 4.20 | 15.67 | 15.68 | 21.16 | 31.65 | |
| 2.75 | 12.58 | 12.57 | 18.71 | 29.48 | |
| Operating Profit | 1.45 | 3.09 | 3.11 | 2.45 | 2.17 |
| OPM % | 34.52% | 19.72% | 19.83% | 11.58% | 6.86% |
| 0.00 | 0.03 | 0.84 | 1.61 | 1.07 | |
| Interest | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 |
| Depreciation | 0.03 | 1.07 | 0.29 | 0.60 | 0.76 |
| Profit before tax | 1.42 | 2.05 | 3.63 | 3.46 | 2.48 |
| Tax % | 26.06% | 24.88% | 25.62% | 25.14% | |
| 1.05 | 1.53 | 2.70 | 2.59 | 1.90 | |
| EPS in Rs | 2.66 | 1.53 | 1.96 | 1.88 | 1.38 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 71% |
| TTM: | 79% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 35% |
| TTM: | -44% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -19% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 10% |
| Last Year: | 7% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 3.95 | 9.99 | 13.78 | 13.78 | 13.78 |
| Reserves | 1.07 | 8.01 | 19.71 | 22.31 | 23.31 |
| 0.40 | 0.10 | 0.09 | 0.09 | 1.18 | |
| 1.63 | 1.51 | 1.83 | 3.00 | 12.20 | |
| Total Liabilities | 7.05 | 19.61 | 35.41 | 39.18 | 50.47 |
| 0.91 | 11.88 | 12.68 | 13.18 | 13.25 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 11.29 |
| 6.14 | 7.73 | 22.73 | 26.00 | 25.93 | |
| Total Assets | 7.05 | 19.61 | 35.41 | 39.18 | 50.47 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| -0.11 | 2.58 | 3.37 | 2.35 | |
| -0.02 | -12.02 | -1.09 | -1.09 | |
| 0.76 | 10.66 | 12.40 | -2.26 | |
| Net Cash Flow | 0.63 | 1.22 | 14.68 | -1.00 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 203.36 | 54.97 | 52.38 | 50.89 |
| Inventory Days | 160.09 | 33.87 | 50.91 | 56.73 |
| Days Payable | 454.65 | 45.55 | 69.43 | 51.21 |
| Cash Conversion Cycle | -91.20 | 43.29 | 33.86 | 56.41 |
| Working Capital Days | 119.06 | 41.46 | 38.41 | 46.06 |
| ROCE % | 17.92% | 14.15% | 9.91% |
Documents
Announcements
-
Outcome of Board Meeting
14 November 2025 - Approved H1 results; invested Rs.11.29 crore in Sadbhavna; IPO proceeds fully utilised (₹808.78 lakh).
-
Structural Digital Database
30 October 2025 - SEBI PIT compliance certificate for quarter ended Sep 30, 2025; SDD maintained; two events captured; no non-compliance.
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
30 October 2025 - Company exempt from filing Regulation 27 corporate governance report for quarter ended 30 Sep 2025.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
14 October 2025 - Certificate under Reg 74(5): not applicable—all shares dematerialised; no remat/demat requests for quarter ended 30 Sep 2025.
-
Shareholders meeting
28 September 2025 - AGM Sept 27, 2025: all six resolutions passed — FY2025 accounts adopted, directors/auditors appointed, MOA object clause altered.
Business Overview:[1][2]
SHL is in the business of Hospitals, pathological laboratory and Pharmacy stores. It operates 2 hospitals viz. Sangani Hospital at Keshod, Gujarat, and Sangani Super Speciality Hospital, Veraval, Gujarat. It also operates 2 pathology laboratories and 2 medical stores.